SUNRISE

1 stories · following the connections

Business

Peregrine Pharmaceuticals Highlights Clinical Data Presentation at AACR 2017 Annual Meeting Supporting Potential of Bavituximab to Enhance Anti-tumor Activity of Immunotherapy

By Nasdaq OMXApr 4, 2017, 12:05 PM UTC